Health care legislation firm Frier Levitt has analyzed FDA enforcement actions in opposition to “exploration only” peptide suppliers. Their summary: the FDA considers a product’s classification determined by its meant use, not its disclaimers. When Internet websites consist of dosage guides, reconstitution Guidance, or hyperlink to boards dis